Compare Torrent Pharma with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs WOCKHARDT - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA WOCKHARDT TORRENT PHARMA/
WOCKHARDT
 
P/E (TTM) x 54.3 -14.7 - View Chart
P/BV x 6.5 1.1 568.9% View Chart
Dividend Yield % 0.8 0.0 23,358.3%  

Financials

 TORRENT PHARMA   WOCKHARDT
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-18
WOCKHARDT
Mar-18
TORRENT PHARMA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs1,5501,012 153.2%   
Low Rs1,144532 215.1%   
Sales per share (Unadj.) Rs354.7355.9 99.7%  
Earnings per share (Unadj.) Rs40.1-60.3 -66.5%  
Cash flow per share (Unadj.) Rs64.2-46.8 -137.3%  
Dividends per share (Unadj.) Rs14.000.01 140,000.0%  
Dividend yield (eoy) %1.00 80,226.5%  
Book value per share (Unadj.) Rs273.1257.8 105.9%  
Shares outstanding (eoy) m169.22110.63 153.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.82.2 175.1%   
Avg P/E ratio x33.6-12.8 -262.5%  
P/CF ratio (eoy) x21.0-16.5 -127.1%  
Price / Book Value ratio x4.93.0 164.7%  
Dividend payout %34.90 -210,579.3%   
Avg Mkt Cap Rs m227,89785,379 266.9%   
No. of employees `00014.76.3 235.0%   
Total wages/salary Rs m11,3539,371 121.2%   
Avg. sales/employee Rs Th4,083.06,295.0 64.9%   
Avg. wages/employee Rs Th772.31,498.3 51.5%   
Avg. net profit/employee Rs Th461.3-1,066.3 -43.3%   
INCOME DATA
Net Sales Rs m60,02139,369 152.5%  
Other income Rs m2,9881,202 248.6%   
Total revenues Rs m63,00940,571 155.3%   
Gross profit Rs m13,49318 73,729.5%  
Depreciation Rs m4,0861,495 273.3%   
Interest Rs m3,0852,555 120.7%   
Profit before tax Rs m9,310-2,830 -329.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m2,529257 983.9%   
Profit after tax Rs m6,781-6,669 -101.7%  
Gross profit margin %22.50 48,360.9%  
Effective tax rate %27.2-9.1 -299.0%   
Net profit margin %11.3-16.9 -66.7%  
BALANCE SHEET DATA
Current assets Rs m52,62333,796 155.7%   
Current liabilities Rs m52,02226,917 193.3%   
Net working cap to sales %1.017.5 5.7%  
Current ratio x1.01.3 80.6%  
Inventory Days Days12079 150.7%  
Debtors Days Days7689 85.4%  
Net fixed assets Rs m85,01639,664 214.3%   
Share capital Rs m846553 153.0%   
"Free" reserves Rs m45,37627,968 162.2%   
Net worth Rs m46,22228,522 162.1%   
Long term debt Rs m41,11521,731 189.2%   
Total assets Rs m142,43281,620 174.5%  
Interest coverage x4.0-0.1 -3,737.1%   
Debt to equity ratio x0.90.8 116.7%  
Sales to assets ratio x0.40.5 87.4%   
Return on assets %6.9-5.0 -137.4%  
Return on equity %14.7-23.4 -62.8%  
Return on capital %14.2-7.7 -184.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m14,5809,807 148.7%   
Fx outflow Rs m3,6001,789 201.3%   
Net fx Rs m10,9808,019 136.9%   
CASH FLOW
From Operations Rs m8,942684 1,306.5%  
From Investments Rs m-47,0706,302 -746.9%  
From Financial Activity Rs m34,174-7,695 -444.1%  
Net Cashflow Rs m-3,655-664 550.5%  

Share Holding

Indian Promoters % 71.5 74.5 96.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.0 2.3 305.2%  
FIIs % 12.6 7.7 163.6%  
ADR/GDR % 0.0 0.1 -  
Free float % 8.8 15.4 57.1%  
Shareholders   26,511 67,757 39.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  PFIZER  

Compare TORRENT PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 72 Points Lower; Capital Goods and Auto Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day marginally lower.

Related Views on News

WOCKHARDT Surges by 11%; BSE HEALTHCARE Index Up 1.1% (Market Updates)

Nov 18, 2019 | Updated on Nov 18, 2019

WOCKHARDT share price has surged by 11% and its current market price is Rs 306. The BSE HEALTHCARE is up by 1.1%. The top gainers in the BSE HEALTHCARE Index are WOCKHARDT (up 11.4%) and GLENMARK PHARMA (up 15.4%). The top losers are LAURUS LABS LTD and BLISS GVS PHARMA .

SANOFI INDIA Surges by 5%; BSE HEALTHCARE Index Up 1.5% (Market Updates)

Nov 18, 2019 | Updated on Nov 18, 2019

SANOFI INDIA share price has surged by 5% and its current market price is Rs 6,820. The BSE HEALTHCARE is up by 1.5%. The top gainers in the BSE HEALTHCARE Index are SANOFI INDIA (up 5.2%) and GLENMARK PHARMA (up 17.2%). The top losers are PIRAMAL ENTERPRISES (down 0.2%) and LAURUS LABS LTD (down 0.4%).

WOCKHARDT Surges by 8%; BSE HEALTHCARE Index Up 0.7% (Market Updates)

Nov 18, 2019 | Updated on Nov 18, 2019

WOCKHARDT share price has surged by 8% and its current market price is Rs 302. The BSE HEALTHCARE is up by 0.7%. The top gainers in the BSE HEALTHCARE Index are WOCKHARDT (up 7.9%) and GLENMARK PHARMA (up 7.9%). The top losers are BLISS GVS PHARMA and CAPLIN POINT .

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Nov 18, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS